Item 7.01. Regulation FD Disclosure

On November 29, 2022, CME Group Inc. ("CME Group") communicated pricing changes to its clients via Special Executive Report 9098, a copy of which has been posted to the company's website. The pricing changes are effective as of February 1, 2023.

The information set forth under Item 7.01 of this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.





Exhibit
Number       Description

104          The cover page from CME Group Inc.'s Current Report on Form 8-K,
             formatted in Inline XBRL.



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses